Pharma Longitudinal Data: Minimum Follow-Up Duration Requirements
Most pharmaceutical companies are building their real-world evidence studies backwards, choosing datasets first, then forcing requirements to fit. This fundamental mistake drives study delays, budget overruns, and regulatory rejections, but there's a specific sequence that FDA guidance actually recommends instead....




















